Baker Bros. Advisors LP

SEC CIK: 0001263508
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ALGS holding history

Aligos Therapeutics, Inc. in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALGS overview All 13F holders of ALGS Full Q2 2026 holdings

Shares (Q2 2026): 83,055
Value: $479.2K
% of portfolio: <0.1%
Quarters held: 22; Since Q1 2021

Holdings of ALGS by Baker Bros. Advisors LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	83,055	$479.2K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	83,055	$617.1K	<0.1%	00.0%	Unchanged	Holders
Q4 2025	83,055	$774.1K	<0.1%	00.0%	Unchanged	Holders
Q3 2025	83,055	$813.9K	<0.1%	00.0%	Unchanged	Holders
Q2 2025	83,055	$598.8K	<0.1%	00.0%	Unchanged	Holders
Q1 2025	83,055	$685.2K	<0.1%	00.0%	Unchanged	Holders
Q4 2024	83,055	$3.31M	<0.1%	00.0%	Unchanged	Holders
Q3 2024	83,055	$719.3K	<0.1%	00.0%	UnchangedConverted for a 1-for-25 split	Holders
Q2 2024	2,076,400	$726.7K	<0.1%	00.0%	Unchanged	Holders
Q1 2024	2,076,400	$2.03M	<0.1%	00.0%	Unchanged	Holders
Q4 2023	2,076,400	$1.38M	<0.1%	00.0%	Unchanged	Holders
Q3 2023	2,076,400	$1.55M	<0.1%	00.0%	Unchanged	Holders
Q2 2023	2,076,400	$2.02M	<0.1%	00.0%	Unchanged	Holders
Q1 2023	2,076,400	$1.81M	<0.1%	00.0%	Unchanged	Holders
Q4 2022	2,076,400	$1.98M	<0.1%	00.0%	Unchanged	Holders
Q3 2022	2,076,400	$2.28M	<0.1%	00.0%	Unchanged	Holders
Q2 2022	2,076,400	$2.51M	<0.1%	00.0%	Unchanged	Holders
Q1 2022	2,076,400	$4.46M	<0.1%	00.0%	Unchanged	Holders
Q4 2021	2,076,400	$24.6M	0.1%	00.0%	Unchanged	Holders
Q3 2021	2,076,400	$32.2M	0.1%	+466,400+29.0%	Added	Holders
Q2 2021	1,610,000	$32.8M	0.1%	00.0%	Unchanged	Holders
Q1 2021	1,610,000	$36.6M	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.